160 related articles for article (PubMed ID: 29983234)
1. Effects of ripasudil, a ROCK inhibitor, on retinal edema and nonperfusion area in a retinal vein occlusion murine model.
Hida Y; Nakamura S; Nishinaka A; Inoue Y; Shimazawa M; Hara H
J Pharmacol Sci; 2018 Jun; 137(2):129-136. PubMed ID: 29983234
[TBL] [Abstract][Full Text] [Related]
2. Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia.
Yamaguchi M; Nakao S; Arita R; Kaizu Y; Arima M; Zhou Y; Kita T; Yoshida S; Kimura K; Isobe T; Kaneko Y; Sonoda KH; Ishibashi T
Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2264-76. PubMed ID: 27124322
[TBL] [Abstract][Full Text] [Related]
3. Effects of kallidinogenase on retinal edema and size of non-perfused areas in mice with retinal vein occlusion.
Nishinaka A; Fuma S; Inoue Y; Shimazawa M; Hara H
J Pharmacol Sci; 2017 Jun; 134(2):86-92. PubMed ID: 28619445
[TBL] [Abstract][Full Text] [Related]
4. Effect of intravitreal Rho kinase inhibitor ripasudil (K-115) on feline retinal microcirculation.
Nakabayashi S; Kawai M; Yoshioka T; Song YS; Tani T; Yoshida A; Nagaoka T
Exp Eye Res; 2015 Oct; 139():132-5. PubMed ID: 26197413
[TBL] [Abstract][Full Text] [Related]
5. The Anti-Inflammatory Effect of Ripasudil (K-115), a Rho Kinase (ROCK) Inhibitor, on Endotoxin-Induced Uveitis in Rats.
Uchida T; Honjo M; Yamagishi R; Aihara M
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5584-5593. PubMed ID: 29084331
[TBL] [Abstract][Full Text] [Related]
6. Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine.
Chihara E; Dimitrova G; Chihara T
Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1257-1264. PubMed ID: 29520478
[TBL] [Abstract][Full Text] [Related]
7. Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.
Ohta Y; Takaseki S; Yoshitomi T
Jpn J Ophthalmol; 2017 Sep; 61(5):423-432. PubMed ID: 28653193
[TBL] [Abstract][Full Text] [Related]
8. Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells.
Kaneko Y; Ohta M; Inoue T; Mizuno K; Isobe T; Tanabe S; Tanihara H
Sci Rep; 2016 Jan; 6():19640. PubMed ID: 26782355
[TBL] [Abstract][Full Text] [Related]
9. Effect of Rho Kinase Inhibitor Ripasudil (K-115) on Isolated Porcine Retinal Arterioles.
Kamiya T; Omae T; Nakabayashi S; Takahashi K; Tanner A; Yoshida A
J Ocul Pharmacol Ther; 2021 Mar; 37(2):104-111. PubMed ID: 33351704
[No Abstract] [Full Text] [Related]
10. Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells.
Okumura N; Okazaki Y; Inoue R; Nakano S; Fullwood NJ; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7560-7. PubMed ID: 26618648
[TBL] [Abstract][Full Text] [Related]
11. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing.
Okumura N; Okazaki Y; Inoue R; Kakutani K; Nakano S; Kinoshita S; Koizumi N
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1284-92. PubMed ID: 26998714
[TBL] [Abstract][Full Text] [Related]
12. Interaction Between Pilocarpine and Ripasudil on Intraocular Pressure, Pupil Diameter, and the Aqueous-Outflow Pathway.
Yamagishi-Kimura R; Honjo M; Komizo T; Ono T; Yagi A; Lee J; Miyata K; Fujimoto T; Inoue T; Tanihara H; Nishida J; Uchida T; Araki Y; Aihara M
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1844-1854. PubMed ID: 29677344
[TBL] [Abstract][Full Text] [Related]
13. Ripasudil Attenuates Lipopolysaccharide (LPS)-Mediated Apoptosis and Inflammation in Pulmonary Microvascular Endothelial Cells via ROCK2/eNOS Signaling.
Yang J; Ruan F; Zheng Z
Med Sci Monit; 2018 May; 24():3212-3219. PubMed ID: 29766980
[TBL] [Abstract][Full Text] [Related]
14. Timolol maleate, a β blocker eye drop, improved edema in a retinal vein occlusion model.
Fuma S; Hidaka Y; Nishinaka A; Yasuda H; Aoshima K; Nakamura S; Hara H; Shimazawa M
Mol Vis; 2023; 29():188-196. PubMed ID: 38222457
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological Role of VEGF on Retinal Edema and Nonperfused Areas in Mouse Eyes With Retinal Vein Occlusion.
Nishinaka A; Inoue Y; Fuma S; Hida Y; Nakamura S; Shimazawa M; Hara H
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4701-4713. PubMed ID: 30267092
[TBL] [Abstract][Full Text] [Related]
16. Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma.
Komizo T; Ono T; Yagi A; Miyata K; Aihara M
Jpn J Ophthalmol; 2019 Jan; 63(1):40-45. PubMed ID: 30368633
[TBL] [Abstract][Full Text] [Related]
17. Topical Ripasudil Suppresses Retinal Ganglion Cell Death in a Mouse Model of Normal Tension Glaucoma.
Akaiwa K; Namekata K; Azuchi Y; Sano H; Guo X; Kimura A; Harada C; Mitamura Y; Harada T
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):2080-2089. PubMed ID: 29677370
[TBL] [Abstract][Full Text] [Related]
18. Axonal Protection by Ripasudil, a Rho Kinase Inhibitor, via Modulating Autophagy in TNF-Induced Optic Nerve Degeneration.
Kitaoka Y; Sase K; Tsukahara C; Kojima K; Shiono A; Kogo J; Tokuda N; Takagi H
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5056-5064. PubMed ID: 28980003
[TBL] [Abstract][Full Text] [Related]
19. Ripasudil alleviated the inflammation of RPE cells by targeting the miR-136-5p/ROCK/NLRP3 pathway.
Gao Z; Li Q; Zhang Y; Gao X; Li H; Yuan Z
BMC Ophthalmol; 2020 Apr; 20(1):134. PubMed ID: 32252692
[TBL] [Abstract][Full Text] [Related]
20. Photocoagulation of the Retinal Nonperfusion Area Prevents the Expression of the Vascular Endothelial Growth Factor in an Animal Model.
Gozawa M; Takamura Y; Miyake S; Matsumura T; Morioka M; Yamada Y; Inatani M
Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5946-5953. PubMed ID: 29098298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
